|
SETD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.46629997033187E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.53520000045759E-08 |
| Normal-vs-Stage2 |
1.40800000003605E-06 |
| Normal-vs-Stage3 |
3.80729999971408E-07 |
| Normal-vs-Stage4 |
1.6829000000218E-06 |
| Stage1-vs-Stage2 |
4.023200E-01 |
| Stage1-vs-Stage3 |
3.741800E-01 |
| Stage1-vs-Stage4 |
1.492380E-01 |
| Stage2-vs-Stage3 |
9.508000E-01 |
| Stage2-vs-Stage4 |
4.303400E-01 |
| Stage3-vs-Stage4 |
3.810400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.83679998883224E-09 |
| Normal-vs-AfricanAmerican |
1.77680000046365E-07 |
| Normal-vs-Asian |
1.426380E-04 |
| Caucasian-vs-AfricanAmerican |
6.689200E-01 |
| Caucasian-vs-Asian |
2.464000E-01 |
| AfricanAmerican-vs-Asian |
3.919000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.82540002505272E-09 |
| Normal-vs-Female |
3.66379999672262E-08 |
| Male-vs-Female |
5.609400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.69052999999808E-05 |
| Normal-vs-Extreme_Weight |
2.95330004895789E-09 |
| Normal-vs-Obese |
2.2855000003652E-07 |
| Normal-vs-Extreme_Obese |
1.076780E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.399800E-01 |
| Normal_Weight-vs-Obese |
8.449400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.579400E-01 |
| Extreme_Weight-vs-Obese |
5.159800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.462000E-01 |
| Obese-vs-Extreme_Obese |
5.591800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.555500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.8312999994794E-08 |
| Normal-vs-Age(61-80Yrs) |
3.02279978825482E-10 |
| Normal-vs-Age(81-100Yrs) |
1.227790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.796200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.991800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.325600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.132000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.232800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.364200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.64290000282242E-08 |
| Normal-VS-Type2 PRCC |
4.36400000000114E-05 |
| Normal-VS-KIRP CIMP |
2.49609999336542E-10 |
| Normal-VS-Unclassified PRCC |
8.49500000343895E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.973400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.48639999999023E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.083240E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.57680000001381E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
5.529900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.462700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.73460000030268E-07 |
| Normal-vs-N1 |
3.02859999967708E-07 |
| Normal-vs-N2 |
7.85170000128232E-08 |
| N0-vs-N1 |
4.660600E-01 |
| N0-vs-N2 |
2.720400E-02 |
| N1-vs-N2 |
5.100100E-02 |
|
|
